Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHKA | P35790 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 7/20 | 0.37 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | RXRB | P28702 | 1/20 | 0.36 |
| ▸ | RXRG | P48443 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | KDM4A | O75164 | 1/20 | 0.34 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6843923 | 0.98 | CNR2 (0.37) | CHKACNR2RXRARXRBRXRG | |
| SCHEMBL6694379 | 0.93 | BDKRB2 (0.35) | CHKACNR2RXRARXRBRXRG | |
| SCHEMBL460361 | 0.90 | CYP3A4 (0.47) | CHKACNR2RXRARXRBRXRG | |
| SCHEMBL8520351 | 0.89 | NPC1 (0.42) | CNR2RXRARXRBRXRGTSHR | |
| SCHEMBL9748667 | 0.87 | ALDH1A1 (0.54) | CNR2GAACNR1CHRM2CHRM4 | |
| Hydrochloric Acid SCHEMBL9879754 | 0.86 | ALDH1A1 (0.53) | CNR2GAACNR1CHRM2CHRM4 | |
| SCHEMBL20871442 | 0.86 | CNR2 (0.47) | CNR2TSHRCNR1 | |
| SCHEMBL11665982 | 0.85 | ALOX5 (0.45) | CNR2TSHR | |
| SCHEMBL9336222 | 0.83 | ICMT (0.40) | CNR2GAATSHR | |
| SCHEMBL1459455 | 0.80 | EGFR (0.44) | CNR2TSHRCHRM2CHRM4CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2494013-B1 | LUBRICATION AND LUBRICATING OIL COMPOSITIONS | CHEMTURA CORP (US) | 2013-09-18 | — | — | EP | disclosed |
| US-20110105374-A1 | Lubrication and lubricating oil compositions | CROMPTON HOLDING CORPORATION | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105374-A1 | Lubrication and lubricating oil compositions | CD99, CTR9, TAF9 | CHKA 87/4885CNR2 2292/4885RXRA 3261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.